Inflammation, haemostatic disturbance, and obesity: Possible link to pathogenesis of diabetic retinopathy in type 2 diabetes

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Tomić, Martina ^a   Ljubić, Spomenka ^a   Kaštelan, Snježana ^b   Gverović Antunica, Antonela ^c   Jazbec, Anamarija ^d   Poljičanin, Tamara ^e  

^a University of Zagreb   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

^c Dubrovnik General Hospital   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD CLOTTING DISORDER; BODY MASS; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; STATISTICAL MODEL; VISUAL ACUITY; WAIST HIP RATIO;

AGED; BLOOD COAGULATION DISORDERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; VISUAL ACUITY; WAIST-HIP RATIO;

EID: 84893840863     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/818671     Document Type: Article

References (64)

1. International Diabetes Federation, IDF Diabetes Atlas Update 2012 2011 5th Brussels, Belgium International Diabetes Federation
2. Roglic G., Unwin N., Mortality attributable to diabetes: estimates for the year 2010. Diabetes Research and Clinical Practice 2010 87 1 15 19 2-s2.0-73749086904 10.1016/j.diabres.2009.10.006
3. Roglic G., Unwin N., Bennett P. H., Mathers C., Tuomilehto J., Nag S., Connolly V., King H., The burden of mortality attributable to diabetes: realistic estimates for th (Pubitemid 41242456)
4. Moss S. E., Klein R., Klein B. E. K., The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1998 105 6 998 1003 2-s2.0-0031807908 10.1016/S0161-6420(98)96025-0 (Pubitemid 28268322)
5. Williams R., Airey M., Baxter H., Forrester J., Kennedy-Martin T., Girach A., Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004 18 10 963 983 2-s2.0-7244240730 10.1038/sj.eye.6701476 (Pubitemid 39430033)
6. Klein R., Klein B. E. K., Moss S. E., Davis M. D., DeMets D. L., The Wisconsin epidemiologic study of diabetic retinopathy. III. prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology 1984 102 4 527 532 2-s2.0-0021191759 (Pubitemid 14127839)
7. Stratton I. M., Kohner E. M., Aldington S. J., Turner R. C., Holman R. R., Manley S. E., Matthews D. R., UKPDS 50: risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia 2001 44 2 156 163 2-s2.0-0035134120 10.1007/s001250051594 (Pubitemid 32156199)
8. Klein R., Klein B. E. K., Moss S. E., Cruickshanks K. J., The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14- year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998 105 10 1801 1815 2-s2.0-0031793875 10.1016/S0161-6420(98)91020-X (Pubitemid 28509717)
9. Porta M., Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Diabetologia 1996 39 6 739 744 2-s2.0-0029970972 10.1007/s001250050504 (Pubitemid 26157632)
10. Stehouwer C. D. A., Lambert J., Donker A. J. M., van Hinsbergh V. W. M., Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovascular Research 1997 34 1 55 68 2-s2.0-0030976646 10.1016/S0008-6363(96)00272-6 (Pubitemid 27261913)
11. Potenza M. A., Gagliardi S., Nacci C., Carratu M. R., Montagnani M., Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Current Medicinal Chemistry 2009 16 1 94 112 2-s2.0-61949439551 10.2174/092986709787002853
12. Vekasi J., Marton Z., Kesmarky G., Cser A., Russai R., Horvath B., Hemorheological alterations in patients with diabetic retinopathy. Clinical Hemorheology and Microcirculation 2001 24 1 59 64 2-s2.0-0035073603 (Pubitemid 32289949)
13. Williams M. D., Nadler J. L., Inflammatory mechanisms of diabetic complications. Current Diabetes Reports 2007 7 3 242 248 2-s2.0-34250712274 10.1007/s11892-007-0038-y (Pubitemid 46951922)
14. Danesh J., Collins R., Appleby P., Peto R., Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Journal of the American Medical Association 1998 279 18 1477 1482 2-s2.0-0032513756 10.1001/jama.279.18.1477 (Pubitemid 28228207)
15. Ridker P. M., Stampfer M. J., Rifai N., Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Journal of the American Medical Association 2001 285 19 2481 2485 2-s2.0-0035897688 (Pubitemid 32433842)
16. van Hecke M. V., Dekker J. M., Nijpels G., Moll A. C., Heine R. J., Bouter L. M., Polak B. C. P., Stehouwer C. D. A., Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn study. Diabetologia 2005 48 7 1300 1306 2-s2.0-23944492556 10.1007/s00125-005-1799-y (Pubitemid 41186094)
17. Gustavsson C., Agardh E., Bengtsson B., Agardh C.-D., TNF- α is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. Journal of Diabetes and Its Complications 2008 22 5 309 316 2-s2.0-42549108719 10.1016/j.jdiacomp.2007.03.001
18. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2007 30 1 S42 S47 10.2337/dc07-S042 (Pubitemid 46048399)
19. Ajani U. A., Ford E. S., Mokdad A. H., Prevalence of high C-reactive protein in persons with serum lipid concentrations within recommended values. Clinical Chemistry 2004 50 9 1618 1622 2-s2.0-4344664519 10.1373/clinchem.2004. 036004 (Pubitemid 39121230)
20. Clauss A., Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Hematologica 1957 17 4 237 246 10.1159/000205234
21. 1c: standardizacija, zlatnog standarda. Biochemia Medica 2006 16 1 25 36 (Pubitemid 44043889)
22. Demacker P. N. M., Boerma G. J. M., Baadenhuijsen H., Evaluation of accuracy of 20 different test kits for the enzymic determination of cholesterol. Clinical Chemistry 1983 29 11 1916 1922 2-s2.0-0020603512 (Pubitemid 13023978)
23. McGowan M. W., Artiss J. D., Strandbergh D. R., Zak B., A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clinical Chemistry 1983 29 3 538 542 2-s2.0-0020680990 (Pubitemid 13160770)
24. Kumanyika S. K., Obarzanek E., Stettler N., Bell R., Field A. E., Fortmann S. P., Franklin B. A., Gillman M. W., Lewis C. E., Poston W. C., Stevens J., Hong Y., Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for prevention (Formerly the Expert Panel on Population and Prevention Science). Circulation 2008 118 4 428 464 2-s2.0-49149109159 10.1161/CIRCULATIONAHA.108.189702
25. de Koning L., Merchant A. T., Pogue J., Anand S. S., Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. European Heart Journal 2007 28 7 850 856 2-s2.0-34548314440 10.1093/eurheartj/ehm026 (Pubitemid 47343598)
26. Aldington S. J., Kohner E. M., Meuer S., Klein R., Sjolie A. K., Methodology for retinal photography and assessment of diabetic retinography: the EURODIAB IDDM complications study. Diabetologia 1995 38 4 437 444 2-s2.0-0028938980 10.1007/s001250050303
27. Mandava N., Yannuzzi L. A., Regillo C. D., Brown G. C., Flynn H. W. Jr., Hypertensive retinopathy. Vitreoretinal Disease: The Essentials 1999 New York, NY, USA Thieme 193 196
28. Wong T. Y., Mitchell P., Hypertensive retinopathy. The New England Journal of Medicine 2004 351 22 2310 2317 2-s2.0-9244261055 10.1056/NEJMra032865 (Pubitemid 39552747)
29. Sokal R. R., Rohlf F. J., Biometry: The Principles and Practice of Statistics in Biological Research 1995 3rd New York, NY, USA W. H. Freeman
30. StatSoft, Electronic statistics textbook. 2011, http://www.statsoft.com/ textbook/
31. Rotimi C., Daniel H., Zhou J., Obisesan A., Chen G., Chen Y., Amoah A., Opoku V., Acheampong J., Agyenim-Boateng K., Eghan B. A. Jr., Oli J., Okafor G., Ofoegbu E., Osotimehin B., Abbiyesuku F., Johnson T., Fasanmade O., Doumatey A., Aje T., Collins F., Dunston G., Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethnicity and Disease 2003 13 2 S110 S117 2-s2.0-0042528353
32. Pollreisz A., Schmidt-Erfurth U., Diabetic cataract-pathogenesis, epidemiology and treatment. Journal of Ophthalmology 2010 2010 8 608751 10.1155/2010/608751
33. Moss S. E., Klein R., Klein B. E. K., Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994 101 6 1061 1070 2-s2.0-0028275559 (Pubitemid 24183163)
34. van Leiden H. A., Dekker J. M., Moll A. C., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Polak B. C. P., Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Archives of Ophthalmology 2003 121 2 245 251 2-s2.0-0037314210 (Pubitemid 36184039)
35. Matthews D. R., Stratton I. M., Aldington S. J., Holman R. R., Kohner E. M., Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Archives of Ophthalmology 2004 122 11 1631 1640 2-s2.0-8144221037 10.1001/archopht.122.11. 1631 (Pubitemid 39473407)
36. Schrier R. W., Estacio R. O., Mehler P. S., Hiatt W. R., Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nature Clinical Practice Nephrology 2007 3 8 428 438 2-s2.0-34547232484 10.1038/ncpneph0559 (Pubitemid 47123588)
37. Chobanian A. V., Bakris G. L., Black H. R., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 10.1001/jama.289.19.2560 (Pubitemid 37430158)
38. Zanchetti A., 2003 European society of hypertension-European society of cardiology guidelines for the management of arterial hypertension. Journal of Hypertension 2003 21 6 1011 1053 2-s2.0-0037527647 10.1097/00004872-200306000- 00001 (Pubitemid 36667855)
39. Venkatramani J., Mitchell P., Ocular and systemic causes of retinopathy in patients without diabetes mellitus. British Medical Journal 2004 328 7440 625 629 2-s2.0-1542405063 (Pubitemid 38340034)
40. Grosso A., Cheung N., Veglio F., Wong T. Y., Similarities and differences in early retinal phenotypes in hypertension and diabetes. Journal of Hypertension 2011 29 9 1667 1675 2-s2.0-80051933364 10.1097/HJH.0b013e3283496655
41. Ikram M. K., Witteman J. C. M., Vingerling J. R., Breteler M. M. B., Hofman A., de Jong P. T. V. M., Retinal vessel diameters and risk of hypertension: the Rotterdam study. Hypertension 2006 47 2 189 194 2-s2.0-31944433594 10.1161/01.HYP.0000199104.61945.33 (Pubitemid 43189762)
42. Wong T., Mitchell P., The eye in hypertension. The Lancet 2007 369 9559 425 435 2-s2.0-33846669377 10.1016/S0140-6736(07)60198-6 (Pubitemid 46188480)
43. Klein R., Klein B. E. K., Moss S. E., Wang Q., Patz A., Kearns T. P., Glew W., Anderson W. B., Tso M. O. M., Gass J. D. M., Burde R., Blood pressure, hypertension and retinopathy in a population. Transactions of the American Ophthalmological Society 1993 91 207 226 2-s2.0-0027771194 (Pubitemid 24045696)
44. van Greevenbroek M. M. J., Schalkwijk C. G., Stehouwer C. D. A., Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. The Netherlands Journal of Medicine 2013 71 4 174 187
45. Kwon H., Pessin J. E., Adipokines mediate inflammation and insulin resistance. Frontiers in Endocrinology 2013 4 71 1 13 10.3389/fendo.2013.00071
46. Fuentes E., Fuentes F., Vilahur G., Badimon L., Palomo I., Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators of Inflammation 2013 2013 11 136584 10.1155/2013/136584
47. Katušić D., Tomić M., Jukić T., Kordić R., Šikić J., Vukojević N., Šarić B., Obesity-a risk factor for diabetic retinopathy in type 2 diabetes? Collegium Antropologicum 2005 29 1 47 50 (Pubitemid 41265098)
48. Raman R., Rani P. K., Gnanamoorthy P., Sudhir R. R., Kumaramanikavel G., Sharma T., Association of obesity with diabetic retinopathy: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetologica 2010 47 3 209 215 2-s2.0-77955663714 10.1007/s00592-009-0113-8
49. Kern T. S., Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental Diabetes Research 2007 2007 14 95103 10.1155/2007/95103
50. Klein B. E. K., Knudtson M. D., Tsai M. Y., Klein R., The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Archives of Ophthalmology 2009 127 9 1175 1182 2-s2.0-70349243143 10.1001/archophthalmol.2009.172
51. Nguyen T. T., Alibrahim E., Islam F. M. A., Klein R., Klein B. E. K., Cotch M. F., Shea S., Wong T. Y., Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care 2009 32 9 1704 1709 2-s2.0-69549112950 10.2337/dc09-0102
52. Madan R., Gupta B., Saluja S., Kansra U. C., Tripathi B. K., Guliani B. P., Coagulation profile in diabetes and its association with diabetic microvascular complications. Journal of Association of Physicians of India 2010 58 481 484 2-s2.0-77955978934
53. Nakamura H., Ito H., Egami Y., Kaji Y., Maruyama T., Koike G., Jingu S., Harada M., Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Research and Clinical Practice 2008 79 2 330 336 2-s2.0-38349129860 10.1016/j.diabres.2007.09.004
54. García-Lorda P., Bulló M., Balanzà R., Salas-Salvadó J., C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. International Journal of Obesity 2006 30 3 468 474 2-s2.0-33644633361 10.1038/sj.ijo.0803182
55. del Cañizo Gómeza F. J., Fernández Pérezb C., Moreno Ruiza I., de Gorospe Pérez-Jáureguia C., Silveira Rodrígueza B., González Losadaa T., Segura Galindoa A., Microvascular complications and risk factors in patients with type 2 diabetes. Endocrinología y Nutrición 2011 58 4 163 168 10.1016/j.endonu. 2011.01.006
56. Scarabin P.-Y., Aillaud M.-F., Amouyel P., Evans A., Luc G., Ferrières J., Arveiler D., Juhan-Vague I., Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction. The Prime study. Thrombosis and Haemostasis 1998 80 5 749 756 2-s2.0-0031744130 (Pubitemid 28521717)
57. Krobot K., Hense H. W., Cremer P., Eberle E., Keil U., Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex: results from the second MONICA Augsburg survey, 1989-1990. Arteriosclerosis and Thrombosis 1992 12 7 780 788 2-s2.0-0026650534
58. Eliasson M., Evrin P.-E., Lundblad D., Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study. Journal of Clinical Epidemiology 1994 47 5 513 524 2-s2.0-0028355816 10.1016/0895-4356(94)90298-4 (Pubitemid 24171216)
59. Cederholm-Williams S. A., Dornan T. L., Turner R. C., The metabolism of fibrinogen and plasminogen related to diabetic retinopathy in man. European Journal of Clinical Investigation 1981 11 2, supplement 1 133 138 2-s2.0-0019811472 (Pubitemid 12180488)
60. Fujisawa T., Ikegami H., Yamato E., Kawaguchi Y., Ueda H., Shintani M., Nojima K., Kawabata Y., Ono M., Nishino T., Noso S., Yamada K., Babaya N., Okamoto N., Ohguro N., Fukuda M., Ogihara T., Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in type 2 diabetes mellitus. Diabetic Medicine 1999 16 6 522 526 2-s2.0-0032707181 10.1046/j.1464-5491.1999. 00111.x
61. Shamai L., Lurix E., Shen M., Novaro G. M., Szomstein S., Rosenthal R., Hernandez A. V., Asher C. R., Association of body mass index and lipid profiles: evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obesity Surgery 2011 21 1 42 47 2-s2.0-78651233867 10.1007/s11695-010-0170-7
62. van Leiden H. A., Dekker J. M., Moll A. C., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Polak B. C. P., Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 2002 25 8 1320 1325 2-s2.0-0036673902 10.2337/diacare.25.8.1320 (Pubitemid 41071139)
63. Jew O. M., Peyman M., Chen T. C., Visvaraja S., Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes. International Journal of Ophthalmology 2012 5 4 499 504
64. Zoppini G., Negri C., Stoico V., Casati S., Pichiri I., Bonora E., Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus. Metabolism 2012 61 1 22 29 2-s2.0-82955213026 10.1016/j.metabol.2011.05.004